Cambricon
688256
China Vanke Co.,Ltd.
000002
Kweichow Moutai
600519
4
Ping An Insurance
601318
5
Semiconductor Manufacturing International Corporation
688981
CN Stock MarketDetailed Quotes
300006 Chongqing Lummy Pharmaceutical
- 3.43
- -0.03-0.87%
Trading Jan 24 09:54 CST
3.62BMarket Cap190.56P/E (TTM)
3.50High3.40Low69.15KlotVolume3.46Open3.46Pre Close23.90MTurnover0.66%Turnover RatioLossP/E (Static)1.06BShares6.4352wk High1.76P/B3.62BFloat Cap2.0352wk Low4.15Limit Up1.06BShs Float21.82Historical High2.77Limit Down2.89%Amplitude2.03Historical Low--Dividend TTM3.46Avg Price40.24KlotAsk--Div YieldTTM100Lot Size27.18KlotBid
Chongqing Lummy Pharmaceutical News
Laimei Pharmaceutical: Announcement on the progress of the controlling shareholder\'s agreement to transfer part of the company\'s shares to the transferee
Laimei Pharmaceutical: Announcement on the Controlling Shareholder\'s Proposed Agreement to Transfer Part of the Company\'s Shares
Laimei Pharmaceuticals: Laimei Pharmaceuticals Simplified Equity Change Report
Laimei Pharmaceuticals: Prompt Notice on Disclosure of Simplified Equity Change Report
Laimei Pharmaceutical: Announcement on changes in shareholders\' shares holding 5% or more and changes in voting rights of controlling shareholders reaching 1%
Laimei Pharmaceutical: Pre-disclosure Notice on Passive Reduction of Some Shares Held by Shareholders Holding 5% or More
Laimei Pharmaceuticals: Guojin Securities Summary Report on Continued Supervision and Sponsorship of Laimei Pharmaceuticals Issuance of Shares to Specific Targets in 2021
Laimei Pharmaceuticals: Shareholder dividend return plan for the next three years (2024-2026)
Laimei Pharmaceuticals: An indicative announcement on the issuance of shares to specific targets, the listing and circulation of restricted shares
Laimei Pharmaceutical: Announcement on the expiration of the passive holdings reduction period for shareholders holding 5% or more
Laimei Pharmaceutical: Announcement on the passive reduction of holdings of some shares held by shareholders holding 5% or more of the shares by more than half
Laimei Pharmaceutical: Pre-disclosure Notice on Passive Reduction of Some Shares Held by Shareholders Holding 5% or More
Laimei Pharmaceutical: Announcement on the progress of share transfers of subsidiary companies and the signing of the “Supplementary Agreement to the Equity Transfer Agreement (2)”
Laimei Pharmaceutical: Chongqing Laimei Pharmaceutical Co., Ltd. Simplified Equity Change Report
Laimei Pharmaceutical: Prompt Notice on Disclosure of a Simplified Statement of Changes in Equity
Laimei Pharmaceutical: Announcement on the change in the controlling shareholder's equity to reach 1%
Laimei Pharmaceutical: Announcement on the progress of the second judicial auction of shares held by shareholders holding 5% or more of the shares
Laimei Pharmaceutical: An indicative announcement on shares held by shareholders holding 5% or more of the shares to be judicially auctioned for the second time
Laimei Pharmaceutical: Announcement on the forensic auction of some of the company's shares held by shareholders holding 5% or more of the shares
Laimei Pharmaceutical: Pre-disclosure announcement on the proposed judicial auction and passive reduction of some of the company's shares held by shareholders holding 5% or more of the shares